Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone methyltransferase activity	NSD1 SETDB1 KMT5B PRDM13 METTL22	2.99e-05	71	101	5	GO:0042054
GeneOntologyMolecularFunction	histone modifying activity	NSD1 CDY1 SETDB1 BRCA2 KMT5B PRDM13 METTL22	1.64e-04	229	101	7	GO:0140993
GeneOntologyMolecularFunction	protein methyltransferase activity	NSD1 SETDB1 KMT5B PRDM13 METTL22	1.77e-04	103	101	5	GO:0008276
GeneOntologyMolecularFunction	cytoskeletal anchor activity	ANK2 ANK3 MAP1A	2.35e-04	24	101	3	GO:0008093
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	NSD1 SETDB1 KMT5B METTL22	3.92e-04	68	101	4	GO:0016279
GeneOntologyMolecularFunction	cytoskeletal protein binding	NPHS1 FLNB ANK2 ANK3 MAP1A ANXA8L1 CEACAM8 FXYD5 ANXA8 C10orf90 ADGRV1 TTBK2 BRCA2 NAV3 FHDC1	4.06e-04	1099	101	15	GO:0008092
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	NSD1 SETDB1 KMT5B METTL22	4.14e-04	69	101	4	GO:0016278
GeneOntologyMolecularFunction	spectrin binding	NPHS1 ANK2 ANK3	6.71e-04	34	101	3	GO:0030507
GeneOntologyMolecularFunction	phosphorylation-dependent protein binding	ANK2 ANK3	1.11e-03	10	101	2	GO:0140031
GeneOntologyMolecularFunction	histone H4K20 methyltransferase activity	NSD1 KMT5B	1.11e-03	10	101	2	GO:0042799
GeneOntologyMolecularFunction	chromatin binding	NSD1 MSL1 NR3C1 PHF21A SETDB1 ARID1B TOX4 SALL1 KMT5B ATAD2B PRDM13	1.28e-03	739	101	11	GO:0003682
GeneOntologyBiologicalProcess	chromatin remodeling	PPM1D NSD1 MSL1 NR3C1 CDY1 YEATS2 SETDB1 ARID1B BRCA2 UBR5 KMT5B ATAD2B PRDM13 METTL22	1.50e-05	741	101	14	GO:0006338
GeneOntologyBiologicalProcess	slit diaphragm assembly	NPHS1 PTPRO	2.37e-05	2	101	2	GO:0036060
GeneOntologyBiologicalProcess	chromatin organization	PPM1D NSD1 MSL1 NR3C1 PHF21A CDY1 YEATS2 SETDB1 ARID1B BRCA2 UBR5 KMT5B ATAD2B PRDM13 METTL22	2.98e-05	896	101	15	GO:0006325
GeneOntologyBiologicalProcess	filtration diaphragm assembly	NPHS1 PTPRO	7.10e-05	3	101	2	GO:0036058
GeneOntologyBiologicalProcess	negative regulation of phospholipase A2 activity	ANXA8L1 ANXA8	7.10e-05	3	101	2	GO:1900138
GeneOntologyBiologicalProcess	protein-DNA complex organization	PPM1D NSD1 MSL1 NR3C1 PHF21A CDY1 YEATS2 SETDB1 ARID1B BRCA2 UBR5 KMT5B ATAD2B PRDM13 METTL22	1.02e-04	999	101	15	GO:0071824
Domain	AnnexinVIII	ANXA8L1 ANXA8	2.78e-05	2	99	2	IPR009115
Domain	SET	NSD1 SETDB1 KMT5B PRDM13	1.02e-04	46	99	4	SM00317
Domain	SET_dom	NSD1 SETDB1 KMT5B PRDM13	1.42e-04	50	99	4	IPR001214
Domain	SET	NSD1 SETDB1 KMT5B PRDM13	1.42e-04	50	99	4	PS50280
Domain	ZU5	ANK2 ANK3	9.77e-04	9	99	2	SM00218
Domain	ZU5	ANK2 ANK3	1.22e-03	10	99	2	PS51145
Domain	SET	NSD1 SETDB1 KMT5B	1.33e-03	41	99	3	PF00856
Domain	ZU5	ANK2 ANK3	1.77e-03	12	99	2	PF00791
Domain	ZU5_dom	ANK2 ANK3	1.77e-03	12	99	2	IPR000906
Domain	ANX	ANXA8L1 ANXA8	2.09e-03	13	99	2	SM00335
Domain	Annexin_repeat_CS	ANXA8L1 ANXA8	2.09e-03	13	99	2	IPR018252
Domain	Annexin	ANXA8L1 ANXA8	2.09e-03	13	99	2	PF00191
Domain	Annexin_repeat	ANXA8L1 ANXA8	2.09e-03	13	99	2	IPR018502
Domain	ANNEXIN	ANXA8L1 ANXA8	2.09e-03	13	99	2	PS00223
Domain	-	ANXA8L1 ANXA8	2.09e-03	13	99	2	1.10.220.10
Domain	Annexin	ANXA8L1 ANXA8	2.43e-03	14	99	2	IPR001464
Domain	Post-SET_dom	NSD1 SETDB1	3.18e-03	16	99	2	IPR003616
Domain	PostSET	NSD1 SETDB1	3.18e-03	16	99	2	SM00508
Domain	POST_SET	NSD1 SETDB1	3.18e-03	16	99	2	PS50868
Domain	SUGAR_TRANSPORT_2	SLC2A10 SLC22A3	3.59e-03	17	99	2	PS00217
Domain	Acyl_Trfase/lysoPLipase	FASN PNPLA8	3.59e-03	17	99	2	IPR016035
Domain	Zinc_finger_PHD-type_CS	NSD1 PHF21A NFX1	4.97e-03	65	99	3	IPR019786
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	FLNB ZGRF1 ICE1 RB1CC1 PHF21A KIAA1671 YEATS2 SETDB1 FASN TOX4 SALL1 BRCA2 UBR5	3.65e-10	418	103	13	34709266
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	FLNB FAM234B AOC1 ANK3 ARHGAP26 FRMPD1 NSD1 ALS2 ZBTB41 TACC2 RPS6KC1 TTBK2 ARID1B VCAN NFX1 OTUD4	1.26e-07	1084	103	16	11544199
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ELOA2 DRP2 ARHGAP26 MUC16 NR3C1 CDY1 YEATS2 TTBK2 ARID1B SALL1 OTUD4 FGD5	4.39e-07	638	103	12	31182584
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MAP1A PPM1D ZGRF1 TACC2 NR3C1 KIAA1671 YEATS2 SETDB1 SALL1 BRCA2 UBR5	1.44e-06	588	103	11	38580884
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	PITPNM2 PPP2R2D TMEM94 SMG5 DMXL1 RPS6KC1 TTC7B NFX1 NAV3 OTUD4	1.56e-06	475	103	10	31040226
Pubmed	Reconstitution of the embryonic kidney identifies a donor cell contribution to the renal vasculature upon transplantation.	NPHS1 SALL1 SIX2	2.98e-06	10	103	3	30718617
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TMEM94 FRMPD1 ALS2 ZNF365 YEATS2 SETDB1 UBR5 NAV3 OTUD4	3.59e-06	407	103	9	12693553
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PITPNM2 PPP2R2D SZT2 ARHGAP26 ICE1 SMG5 ADGRV1 PHF21A ARID1B HECW2	4.06e-06	529	103	10	14621295
Pubmed	Fgf8 promotes survival of nephron progenitors by regulating BAX/BAK-mediated apoptosis.	NPHS1 SALL1 SIX2	5.44e-06	12	103	3	36527791
Pubmed	TaqI polymorphisms at the annexin VIII locus (ANX8).	ANXA8L1 ANXA8	8.69e-06	2	103	2	1364010
Pubmed	Annexin A8 controls leukocyte recruitment to activated endothelial cells via cell surface delivery of CD63.	ANXA8L1 ANXA8	8.69e-06	2	103	2	24769558
Pubmed	Cooperative binding promotes demand-driven recruitment of AnxA8 to cholesterol-containing membranes.	ANXA8L1 ANXA8	8.69e-06	2	103	2	29306076
Pubmed	Bone matrix regulates osteoclast differentiation and annexin A8 gene expression.	ANXA8L1 ANXA8	8.69e-06	2	103	2	21344395
Pubmed	Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.	ANXA8L1 ANXA8	8.69e-06	2	103	2	16203777
Pubmed	Annexins: linking Ca2+ signalling to membrane dynamics.	ANXA8L1 ANXA8	8.69e-06	2	103	2	15928709
Pubmed	Clinicopathological Impact of Gene Polymorphism of Nephrin and Glucocorticoid Receptor Genes in Egyptian Children with Nonfamilial Nephrotic Syndrome.	NPHS1 NR3C1	8.69e-06	2	103	2	35946274
Pubmed	The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.	ANK2 ANK3	8.69e-06	2	103	2	11781319
Pubmed	Structural basis of diverse membrane target recognitions by ankyrins.	ANK2 ANK3	8.69e-06	2	103	2	25383926
Pubmed	Annexins: from structure to function.	ANXA8L1 ANXA8	8.69e-06	2	103	2	11917092
Pubmed	Annexin A8 identifies a subpopulation of transiently quiescent c-kit positive luminal progenitor cells of the ductal mammary epithelium.	ANXA8L1 ANXA8	8.69e-06	2	103	2	25803307
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ANK3 PPP2R2D PPM1D TPTE2 RB1CC1 ITPR2 KIAA1671 ARID1B TOX4 TTC7B CEBPZ OTUD4 SIX2	1.38e-05	1049	103	13	27880917
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PITPNM2 FLNB RAP1GAP ANK2 ANK3 MAP1A PRR36 ARHGAP26 ITPR2 FASN TTC7B HECW2 VCAN OTUD4 LRRFIP1	2.08e-05	1431	103	15	37142655
Pubmed	Dopamine activates astrocytes in prefrontal cortex via α1-adrenergic receptors.	ITPR2 SLC22A3	2.60e-05	3	103	2	36170823
Pubmed	Specific expression of annexin A8 in adult murine stratified epithelia.	ANXA8L1 ANXA8	2.60e-05	3	103	2	17082908
Pubmed	The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells.	ANK2 ANK3	2.60e-05	3	103	2	15611082
Pubmed	Human ankyrins and their contribution to disease biology: An update.	ANK2 ANK3	2.60e-05	3	103	2	33410423
Pubmed	Sall4 Is Transiently Expressed in the Caudal Wolffian Duct and the Ureteric Bud, but Dispensable for Kidney Development.	SALL1 SIX2	2.60e-05	3	103	2	23825698
Pubmed	The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers.	MUC16 FASN	2.60e-05	3	103	2	32698888
Pubmed	Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue.	ANK2 ANK3	2.60e-05	3	103	2	34289389
Pubmed	Overexpression of Sall1 in vivo leads to reduced body weight without affecting kidney development.	SALL1 SIX2	2.60e-05	3	103	2	20053786
Pubmed	Vascular anticoagulant beta: a novel human Ca2+/phospholipid binding protein that inhibits coagulation and phospholipase A2 activity. Its molecular cloning, expression and comparison with VAC-alpha.	ANXA8L1 ANXA8	2.60e-05	3	103	2	2530088
Pubmed	BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer	PPM1D RB1CC1 BRCA2	3.23e-05	21	103	3	20301425
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ANK3 NSD1 KIAA1671 YEATS2 FASN ARID1B TOX4 CEBPZ LRRFIP1	3.84e-05	549	103	9	38280479
Pubmed	Fras1, a basement membrane-associated protein mutated in Fraser syndrome, mediates both the initiation of the mammalian kidney and the integrity of renal glomeruli.	NPHS1 SALL1 SIX2	4.28e-05	23	103	3	18787044
Pubmed	Hepatic Glucocorticoid Receptor Plays a Greater Role Than Adipose GR in Metabolic Syndrome Despite Renal Compensation.	NR3C1 FASN GYS2	4.88e-05	24	103	3	27754788
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	DDX59 ITPR2 RPS6KC1 SETDB1 ARID1B UBR5 CEBPZ ANAPC4	5.13e-05	440	103	8	34244565
Pubmed	GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression.	NR3C1 KMT5B	5.19e-05	4	103	2	19074285
Pubmed	Refining transcriptional programs in kidney development by integration of deep RNA-sequencing and array-based spatial profiling.	SALL1 SIX2	5.19e-05	4	103	2	21888672
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MAP1A TACC2 NR3C1 PHF21A YEATS2 RNF220 SALL1 BRCA2	5.47e-05	444	103	8	34795231
Pubmed	CK2-regulated schwannomin-interacting protein IQCJ-SCHIP-1 association with AnkG contributes to the maintenance of the axon initial segment.	ANK2 ANK3	8.64e-05	5	103	2	25950943
Pubmed	Glial ankyrins facilitate paranodal axoglial junction assembly.	ANK2 ANK3	8.64e-05	5	103	2	25362471
Pubmed	The growth factor midkine is modulated by both glucocorticoid and retinoid in fetal lung development.	NR3C1 VCAN	8.64e-05	5	103	2	12495930
Pubmed	An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.	ANK2 ANK3	8.64e-05	5	103	2	19109891
Pubmed	Axon initial segment-associated microglia.	ANK3 VCAN	8.64e-05	5	103	2	25653382
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ANK2 MAP1A TACC2 ICE1 NR3C1 PHF21A KIAA1671 YEATS2 FASN TOX4 ANAPC4	1.04e-04	934	103	11	33916271
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PITPNM2 SZT2 TMEM94 ARHGAP26 NSD1 ICE1 SMG5 MDFI GBA2 ITPR2 FASN NFX1	1.07e-04	1105	103	12	35748872
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NSD1 MSL1 ICE1 YEATS2 ARID1B TOX4 SALL1 BRCA2 CEBPZ ATAD2B ANAPC4	1.25e-04	954	103	11	36373674
Pubmed	In vivo assembly of the axon initial segment in motor neurons.	ANK2 ANK3	1.29e-04	6	103	2	23728480
Pubmed	SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance.	NPHS1 SIX2	1.29e-04	6	103	2	33514561
Pubmed	Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.	PSD2 PPP2R2D BRCA2 UBR5	1.34e-04	87	103	4	17148452
Pubmed	Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice.	ANK2 ANK3	1.81e-04	7	103	2	7495297
Pubmed	A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes.	PHF21A BRCA2	1.81e-04	7	103	2	12032298
Pubmed	The genetic origin of mouse annexin VIII.	ANXA8L1 ANXA8	1.81e-04	7	103	2	9434938
Pubmed	Elongator and codon bias regulate protein levels in mammalian peripheral neurons.	BRCA2 VCAN	1.81e-04	7	103	2	29497044
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	MUC16 RB1CC1 YEATS2 ARID1B SALL1 UBR5 ANAPC4	1.83e-04	396	103	7	26687479
Pubmed	The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation.	NPHS1 NR3C1 SALL1 SIX2	1.88e-04	95	103	4	20843830
Pubmed	SETDB1 Links the Meiotic DNA Damage Response to Sex Chromosome Silencing in Mice.	SETDB1 BRCA2	2.40e-04	8	103	2	30393076
Pubmed	MYH9-dependent polarization of ATG9B promotes colorectal cancer metastasis by accelerating focal adhesion assembly.	FLNB FASN	2.40e-04	8	103	2	34131310
Pubmed	Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene.	BRCA2 SCG3	2.40e-04	8	103	2	9063750
Pubmed	Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders.	ANK2 MAP1A ARID1B	2.86e-04	43	103	3	36950384
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	ARHGAP26 FRMPD1 ADGRV1 ITPR2 UBR5 VCAN PNPLA8	3.01e-04	430	103	7	32581705
Pubmed	Sall1 maintains nephron progenitors and nascent nephrons by acting as both an activator and a repressor.	SALL1 SIX2	3.08e-04	9	103	2	24744442
Pubmed	Potent and specific Atg8-targeting autophagy inhibitory peptides from giant ankyrins.	ANK2 ANK3	3.08e-04	9	103	2	29867141
Pubmed	Six1 is required for the early organogenesis of mammalian kidney.	SALL1 SIX2	3.08e-04	9	103	2	12783782
Pubmed	Genetic Steroid-Resistant Nephrotic Syndrome Overview	NPHS1 PTPRO	3.08e-04	9	103	2	34436835
Pubmed	β-Catenin overexpression in the metanephric mesenchyme leads to renal dysplasia genesis via cell-autonomous and non-cell-autonomous mechanisms.	NPHS1 SIX2	3.08e-04	9	103	2	24637293
Pubmed	Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy.	NPHS1 P3H2	3.08e-04	9	103	2	35499085
Pubmed	TBR1 regulates autism risk genes in the developing neocortex.	ANK2 ARID1B	3.08e-04	9	103	2	27325115
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FLNB ZBTB41 ICE1 ITPR2 RPS6KC1 KIAA1671 HECW2 ATAD2B PRDM13	3.47e-04	736	103	9	29676528
Pubmed	Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development.	NPHS1 SALL1 SIX2	3.49e-04	46	103	3	23555292
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	ANK2 ANK3	3.85e-04	10	103	2	22159418
Pubmed	Role of fibroblast growth factor receptors 1 and 2 in the metanephric mesenchyme.	SALL1 SIX2	3.85e-04	10	103	2	16442091
Pubmed	Esco2 is a novel corepressor that associates with various chromatin modifying enzymes.	PHF21A SETDB1	3.85e-04	10	103	2	18501190
Pubmed	A cohesin-RAD21 interactome.	FLNB PPM1D YEATS2 FASN ANAPC4	3.97e-04	208	103	5	22145905
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	FLNB RAP1GAP ANK2 ANK3 SMG5 ZNF365 SETDB1 RNF220 TTC7B SCG3 NAV3 LRRFIP1	4.25e-04	1285	103	12	35914814
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	COL12A1 EMILIN2 VCAN	4.47e-04	50	103	3	23658023
Pubmed	Strain background effects and genetic modifiers of hearing in mice.	MAP1A ADGRV1	4.69e-04	11	103	2	16579977
Pubmed	Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin.	NPHS1 PTPRO	4.69e-04	11	103	2	11435469
Pubmed	OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.	FASN OTUD4	4.69e-04	11	103	2	36411454
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FLNB NSD1 MSL1 YEATS2 FASN TOX4	4.76e-04	332	103	6	37433992
Pubmed	Tagging genes with cassette-exchange sites.	FLNB PPP2R2D ARHGAP26 SMG5 DMXL1 RNF220	4.99e-04	335	103	6	15741177
Pubmed	Calcium signaling induces partial EMT and renal fibrosis in a Wnt4mCherry knock-in mouse model.	ANK2 NAV3 SIX2	5.31e-04	53	103	3	38653356
Pubmed	Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.	FLNB FASN TOX4	5.61e-04	54	103	3	25631074
Pubmed	The embryonic ontogeny of the gonadal somatic cells in mice and monkeys.	SALL1 SIX2	5.62e-04	12	103	2	33951437
Pubmed	Stromal prorenin receptor is critical for normal kidney development.	SALL1 SIX2	5.62e-04	12	103	2	30943054
Pubmed	WT1 targets Gas1 to maintain nephron progenitor cells by modulating FGF signals.	NPHS1 SIX2	5.62e-04	12	103	2	25804736
Pubmed	Dicer function is required in the metanephric mesenchyme for early kidney development.	SALL1 SIX2	5.62e-04	12	103	2	24500693
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	PITPNM2 FLNB ANK2 ANK3 MAP1A ANXA8L1 ANXA8 TACC2 RPS6KC1 NAV3 LRRFIP1	5.66e-04	1139	103	11	36417873
Pubmed	Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.	FLNB MAP1A FASN UBR5 LRRFIP1	5.79e-04	226	103	5	31452512
Pubmed	The DNA sequence and comparative analysis of human chromosome 10.	PPP2R2D WBP1L ANXA8L1 C10orf90 TACC2 ZNF365	5.82e-04	345	103	6	15164054
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	FLNB USP37 SETDB1 RNF220 UBR5 NFX1 OTUD4	5.86e-04	481	103	7	28190767
Pubmed	A protein interaction landscape of breast cancer.	ANK3 SMG5 KIAA1671 ARID1B TOX4 BRCA2 UBR5 ANAPC4	6.08e-04	634	103	8	34591612
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	PPP2R2D ANXA8L1 ANXA8 MSL1 TACC2 TTBK2 FASN ARID1B TOX4 UBR5 ANAPC4	6.35e-04	1155	103	11	20360068
Pubmed	New nomenclature for chromatin-modifying enzymes.	NSD1 SETDB1 KMT5B	6.57e-04	57	103	3	18022353
Pubmed	Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease.	SALL1 SIX2	6.63e-04	13	103	2	38692273
Pubmed	The transcription factor Sry-related HMG box-4 (SOX4) is required for normal renal development in vivo.	NPHS1 SIX2	6.63e-04	13	103	2	23559562
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	FLNB FASN UBR5 VCAN OTUD4	6.90e-04	235	103	5	30258100
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	YEATS2 FASN TOX4 SALL1 BRCA2 UBR5	6.95e-04	357	103	6	37059091
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	FLNB DENND4A COL12A1 HSPB3 ANK2 ARID1B ZNF417	7.10e-04	497	103	7	23414517
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	COL12A1 EMILIN2 ANXA8 VCAN	7.13e-04	135	103	4	28675934
Interaction	PHF21A interactions	FLNB ZGRF1 ICE1 RB1CC1 PHF21A KIAA1671 YEATS2 TOX4 SALL1 BRCA2 UBR5	1.09e-06	343	100	11	int:PHF21A
Interaction	RCOR1 interactions	ZGRF1 ICE1 NR3C1 RB1CC1 PHF21A YEATS2 FASN TOX4 SALL1 BRCA2 UBR5 LRRFIP1	6.12e-06	494	100	12	int:RCOR1
Interaction	NUP43 interactions	SZT2 NSD1 MSL1 ICE1 PHF21A YEATS2 RNF220 ARID1B BRCA2 UBR5 CEBPZ ATAD2B ANAPC4	1.30e-05	625	100	13	int:NUP43
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	NSD1 SETDB1 KMT5B	3.32e-04	34	72	3	487
GeneFamily	Annexins\|Endogenous ligands	ANXA8L1 ANXA8	1.19e-03	13	72	2	404
Coexpression	ONKEN_UVEAL_MELANOMA_UP	RAP1GAP ANK2 WBP1L FXYD5 MSL1 TACC2 RB1CC1 PHF21A DMXL1 ITPR2 SETDB1 FASN UBR5 LRRFIP1	2.62e-06	790	103	14	M12490
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	1.10e-08	183	103	8	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	1.36e-08	188	103	8	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	1.60e-08	192	103	8	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	1.60e-08	192	103	8	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PITPNM2 ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	1.73e-08	194	103	8	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	1.88e-08	196	103	8	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 TACC2 ADGRV1 RNF220 FASN P3H2 SLC22A3 FHDC1	2.03e-08	198	103	8	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	2.20e-08	200	103	8	b535323e18d9fb0dde1e0026df142c831e48c29f
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	2.09e-07	180	103	7	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	IPF-Epithelial-ATII\|IPF / Disease state, Lineage and Cell class	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	2.52e-07	185	103	7	563b4e6d92bb5d77a3829556116a8e99aebac615
ToppCell	368C-Epithelial_cells-Epithelial-E_(AT2)\|368C / Donor, Lineage, Cell class and subclass (all cells)	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	2.91e-07	189	103	7	6f2322d017b74a1757c81d6e06f50ead8c3dd0cc
ToppCell	368C-Epithelial_cells-Epithelial-E_(AT2)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	2.91e-07	189	103	7	926b5fa3064b501a57ba78583e8af33532add455
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	3.02e-07	190	103	7	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	368C-Epithelial_cells\|368C / Donor, Lineage, Cell class and subclass (all cells)	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	3.02e-07	190	103	7	459811e88d3001816c2d89034e0921c24918c17f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RAP1GAP ANK3 C10orf90 ADGRV1 RNF220 P3H2 SLC22A3	3.13e-07	191	103	7	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	3.13e-07	191	103	7	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	3.13e-07	191	103	7	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	3.24e-07	192	103	7	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RAP1GAP ANK3 C10orf90 ADGRV1 RNF220 P3H2 SLC22A3	3.24e-07	192	103	7	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	3.35e-07	193	103	7	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	3.35e-07	193	103	7	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	3.35e-07	193	103	7	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	3.85e-07	197	103	7	bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell	Biopsy_Other_PF-Epithelial-AT2\|Biopsy_Other_PF / Sample group, Lineage and Cell type	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	4.12e-07	199	103	7	9a65acfe9bf500db72142469cf17bf0973540001
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	4.12e-07	199	103	7	a38a981cffa61c8444a980916de7414e689a1b63
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3 FHDC1	4.12e-07	199	103	7	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLNB SZT2 FXYD5 EMILIN2 VCAN FGD5 LRRFIP1	4.12e-07	199	103	7	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	4.26e-07	200	103	7	3c251ad03fbbdae91dfd9037880ba43adbb03807
ToppCell	Lung_Parenchyma-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 FHDC1	4.26e-07	200	103	7	c2bde99b3bc7a8740441c1a0c1394892b940b857
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	4.26e-07	200	103	7	c905451425d1c24773bb0ca69bcf0309b277d2f1
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLNB ANK3 MUC16 TACC2 ADGRV1 KIAA1671 SLC22A3	4.26e-07	200	103	7	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	4.26e-07	200	103	7	65c83a3f6ee2a10bcb5b95076696232c6373a7b4
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	4.26e-07	200	103	7	23088edc62bf7d4db890937bfd7925dc316fcc76
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	4.26e-07	200	103	7	40e969883bc302e8fbc6b6ab9814529dc1472902
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 FHDC1	4.26e-07	200	103	7	3ff9abd5e07780a59d5571da906fa15f00a1d5c2
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-AT2-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	4.26e-07	200	103	7	ad9cdc82a647d379abc713a56db0e11bb6494106
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	4.26e-07	200	103	7	acc771a902cf2f060c3eb9aedb72a256f5778a6c
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	4.26e-07	200	103	7	b2d61bc3afac0d78aa30082760da5b1a15d1fad2
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT2-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	4.26e-07	200	103	7	ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-AT2-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	4.26e-07	200	103	7	35c05cae30cd6b323d2662f1396ddeab08bc75fc
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 FHDC1	4.26e-07	200	103	7	9970e9bde6aa2ff3aef60dcb065ff15b7463e147
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RAP1GAP ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	4.26e-07	200	103	7	eb44d1f80ecaac3a022cd04ab16dc36151e45488
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)\|367C / Donor, Lineage, Cell class and subclass (all cells)	RAP1GAP ANK3 TACC2 ADGRV1 FASN FHDC1	4.44e-06	184	103	6	0ba243cbf69b4fe6ae100a7f0314317bec38026c
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	4.44e-06	184	103	6	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	RAP1GAP ANK3 TACC2 ADGRV1 FASN FHDC1	4.44e-06	184	103	6	2a8338e94937686a148b5433515700ca0f674058
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	4.72e-06	186	103	6	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	Control-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	4.72e-06	186	103	6	f4b6e401e19a71beddc73d8a1e08359f7c4025cf
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RAP1GAP ANK3 TACC2 ADGRV1 P3H2 SLC22A3	4.87e-06	187	103	6	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	RAP1GAP ANK3 FASN P3H2 SLC22A3 FHDC1	4.87e-06	187	103	6	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ANK3 TACC2 ADGRV1 FASN P3H2 SLC22A3	5.02e-06	188	103	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	RAP1GAP ANK2 PRR36 MUC16 TACC2 P3H2	5.02e-06	188	103	6	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	ANK3 TACC2 ADGRV1 P3H2 SLC22A3 FHDC1	5.17e-06	189	103	6	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK2 MAP1A CDHR3 ITPR2 NAV3 KIAA2012	5.17e-06	189	103	6	cd4746ea6ae48a7dd14a2960d38d9445a738cf2c
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	FLNB ARHGAP26 ITPR2 KIAA1671 VCAN FGD5	5.17e-06	189	103	6	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	Control-Epithelial-ATII\|Control / Disease state, Lineage and Cell class	ANK3 TACC2 FASN P3H2 SLC22A3 FHDC1	5.33e-06	190	103	6	d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	5.50e-06	191	103	6	6cb2c107bc674aa173b4009f320a1687a76f3979
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	5.83e-06	193	103	6	8646e573f2d2ff175f3d02bfdf214e65f3b614d3
ToppCell	normal_Lung-Epithelial_cells-AT2\|normal_Lung / Location, Cell class and cell subclass	RAP1GAP ANK3 FASN P3H2 SLC22A3 FHDC1	5.83e-06	193	103	6	80ad1bdc50ecb8a50362f718248441cae20904a6
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 PHF21A KIAA1671 HECW2 NAV3 FGD5	5.83e-06	193	103	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	6.19e-06	195	103	6	6617abca0009ad3d8731f515f91ab275f9ea4c40
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	6.19e-06	195	103	6	6867f9c56ea27a17c8c4099aae0d79903c3748a5
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	6.19e-06	195	103	6	fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	6.19e-06	195	103	6	3e24570def013d5b0b1ef1d7a5ced7dfd922590b
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	6.19e-06	195	103	6	955a0a7244cd7eaf006a39e1bd03333baf6f30a4
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	6.19e-06	195	103	6	37aa6e4123d37de4de42ca68d3020f2a7686ce02
ToppCell	3'-Parenchyma_lung-Epithelial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	6.19e-06	195	103	6	eec187c087e432417bc346c5d3ead72f58bf3215
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	6.37e-06	196	103	6	82b117be41f2e7d677a42d2a5198726eeccb16d0
ToppCell	cellseq-Epithelial-Epithelial_Alveolar\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RAP1GAP TACC2 FASN P3H2 SLC22A3 FHDC1	6.37e-06	196	103	6	a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17
ToppCell	medial-2-Epithelial-Alveolar_Epithelial_Type_2\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RAP1GAP ANK3 FASN P3H2 SLC22A3 FHDC1	6.75e-06	198	103	6	102a4cbb138adbfba11ed955420095daa098532f
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TACC2 ADGRV1 RNF220 P3H2 SLC22A3 FHDC1	6.75e-06	198	103	6	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	medial-Epithelial-Alveolar_Epithelial_Type_2-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RAP1GAP ANK3 FASN P3H2 SLC22A3 FHDC1	6.75e-06	198	103	6	7caeed2d5dc78866023c8f38edcec9886baa9f2c
ToppCell	ASK428-Epithelial-Type_2\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	RAP1GAP ANK3 FASN P3H2 SLC22A3 FHDC1	6.75e-06	198	103	6	ec0d1801363adb70c6a26655b79d12b438c7417d
ToppCell	medial-Epithelial-Alveolar_Epithelial_Type_2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RAP1GAP ANK3 FASN P3H2 SLC22A3 FHDC1	6.75e-06	198	103	6	53e5d76831d70b9a476f3ef3a81e13eda974d543
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL12A1 ANK2 MDFI P3H2 SLC22A3 VCAN	6.95e-06	199	103	6	9b2262edbdec89166d895ab97527e0ee5f9b6010
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL12A1 ANK2 MDFI P3H2 SLC22A3 VCAN	6.95e-06	199	103	6	251b3643dcd8f4645b17101bd716e66f12a20e88
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT2\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3	6.95e-06	199	103	6	fa5ddba3ac1ebe712cd4cdc3f20339f7c715d039
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL12A1 ANK2 MDFI P3H2 SLC22A3 VCAN	6.95e-06	199	103	6	117f4f43b6c06dda553799b1063e827bce697370
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RAP1GAP ANK3 ADGRV1 FASN P3H2 SLC22A3	7.15e-06	200	103	6	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT2-1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3	7.15e-06	200	103	6	cf1991853e10c562edae9a0d71a209f35b07db80
ToppCell	distal-Epithelial-Alveolar_Epithelial_Type_2-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RAP1GAP ANK3 FASN P3H2 SLC22A3 FHDC1	7.15e-06	200	103	6	bcaab6cb7f165dfcf3fb499497b361b062f9dbff
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3	7.15e-06	200	103	6	7618ae284625c5c121bcc00eb9f07e5b1e3adf23
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	RAP1GAP ANK3 TACC2 FASN P3H2 SLC22A3	7.15e-06	200	103	6	23b319bf7e5ae03e5baa777c951da9bfc97cca8c
ToppCell	facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP26 FXYD5 EMILIN2 VCAN PRDM13	2.94e-05	154	103	5	1e088b0d4a44267f46a9b643f46a1aba784686b1
ToppCell	E16.5-Immune-Immune_Myeloid-Granulocytic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FXYD5 EMILIN2 SAMSN1 SLC22A3 KIAA2012	3.03e-05	155	103	5	c648512305166d2a2f0e284c127bc802af908071
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122\|Adult / Lineage, Cell type, age group and donor	PITPNM2 ANK3 TACC2 ADGRV1 SLC22A3	3.23e-05	157	103	5	31d1bd9138c60e8485664ec4144f987226e3eef9
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	PITPNM2 ANK3 TACC2 ADGRV1 SLC22A3	3.86e-05	163	103	5	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RAP1GAP ANK3 TACC2 FASN FHDC1	3.97e-05	164	103	5	b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RAP1GAP ANK3 TACC2 FASN FHDC1	3.97e-05	164	103	5	3aea6207a011ad55a1aeb2ed9fb54d31b23694b5
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP HSPB3 PTPRO VCAN METTL22	3.97e-05	164	103	5	0853e75b60b2a78257b660910c3ee15b09c5f5b0
ToppCell	droplet-Fat-Scat-18m-Myeloid-monocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP26 EMILIN2 SAMSN1 PTPRO VCAN	4.09e-05	165	103	5	015f8f408d7fd17292defe63fa02b16eed642dfb
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FXYD5 EMILIN2 SAMSN1 PTPRO VCAN	4.33e-05	167	103	5	8aacb102c1b0067a86eb6c2acedd07667198487d
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FXYD5 EMILIN2 SAMSN1 PTPRO VCAN	4.71e-05	170	103	5	a6f2a792980e6a1025b8f1b0eda442a555938488
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	FLNB COL12A1 ANK3 TACC2 ADGRV1	4.71e-05	170	103	5	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL12A1 SALL1 SLC22A3 VCAN FGD5	4.85e-05	171	103	5	a5634b76476b8b2488a706bbab5141f7bd94631f
ToppCell	Bronchial_Brush-Epithelial-Ionocytes\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ANK2 ITPR2 SALL1 P3H2 NAV3	5.12e-05	173	103	5	e1de849dcd96063136bdac87e050ddbd55cabdcc
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	RAP1GAP TACC2 SLC2A10 SLC22A3 FHDC1	5.12e-05	173	103	5	ef8d720b99470fe1953661f6e66bc0366266bdb6
ToppCell	Bronchial_Brush-Epithelial-Ionocytes\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	ANK2 ITPR2 SALL1 P3H2 NAV3	5.12e-05	173	103	5	f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL12A1 SALL1 SLC22A3 VCAN FGD5	5.41e-05	175	103	5	e78bf0c33a741bb97e987e41ac33da9e623a08ec
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5\|TCGA-Skin / Sample_Type by Project: Shred V9	COL12A1 MAP1A HECW2 VCAN KIAA2012	5.86e-05	178	103	5	ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 ADGRV1 RNF220 P3H2 SLC22A3	6.02e-05	179	103	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
Disease	Malignant neoplasm of breast	FLNB RAP1GAP DDX59 ANK2 PPM1D FRMPD1 TACC2 RB1CC1 ZNF365 SLC2A10 FASN ARID1B BRCA2 P3H2 FGD5 LRRFIP1	6.48e-07	1074	100	16	C0006142
Disease	sitting height ratio	NSD1 C10orf90 ARID1B ATAD2B	2.75e-05	51	100	4	EFO_0007118
Disease	BREAST CANCER	PPM1D RB1CC1 BRCA2	4.81e-05	21	100	3	114480
Disease	Malignant tumor of breast	PPM1D RB1CC1 BRCA2	1.04e-04	27	100	3	cv:C0006142
Disease	Breast neoplasm	PPM1D RB1CC1 BRCA2	1.04e-04	27	100	3	cv:C1458155
Disease	Familial cancer of breast	PPM1D RB1CC1 BRCA2	1.04e-04	27	100	3	cv:C0346153
Disease	hematocrit	AOC1 ARHGAP26 WBP1L ADGRV1 NR3C1 USP37 ITPR2 TTBK2 ARID1B SALL1 GYS2 FGD5	1.61e-04	1011	100	12	EFO_0004348
Disease	C-reactive protein measurement	RAP1GAP ANK3 MAP1A PPP2R2D CDHR3 PHF21A YEATS2 SALL1 SCG3 GYS2 RP1L1 KIAA2012 ANAPC4	2.19e-04	1206	100	13	EFO_0004458
Disease	Neurodevelopmental Disorders	ANK2 PPM1D ARID1B KMT5B	2.88e-04	93	100	4	C1535926
Disease	testosterone measurement	DENND4A AOC1 ANK2 ANK3 MAP1A ARHGAP26 WBP1L NR3C1 FASN ARID1B P3H2 SLC22A3 ANAPC4	3.73e-04	1275	100	13	EFO_0004908
Disease	Breast Carcinoma	PPM1D RB1CC1 ZNF365 SLC2A10 FASN ARID1B BRCA2 FGD5	4.97e-04	538	100	8	C0678222
Disease	neuroblastoma (is_implicated_in)	NSD1 ARID1B	5.03e-04	10	100	2	DOID:769 (is_implicated_in)
Disease	renal Wilms' tumor (is_implicated_in)	SALL1 SIX2	5.03e-04	10	100	2	DOID:5176 (is_implicated_in)
Disease	suicide	FXYD5 RPS6KC1 RP1L1	6.59e-04	50	100	3	EFO_0007624
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	PPP2R2D ITPR2	7.34e-04	12	100	2	DOID:1441 (implicated_via_orthology)
Disease	revision of total hip arthroplasty	ICE1 RXFP3	1.01e-03	14	100	2	EFO_0020973
Disease	mean corpuscular hemoglobin concentration	DENND4A SMG5 DMXL1 ITPR2 TTBK2 UBR5 HECW2 ATAD2B RP1L1 OTUD4 KIAA2012	1.31e-03	1105	100	11	EFO_0004528
Disease	sexual dimorphism measurement	PITPNM2 AOC1 ARHGAP26 WBP1L NSD1 MSL1 NR3C1 PHF21A SETDB1 ATAD2B OTUD4	1.32e-03	1106	100	11	EFO_0021796
Disease	melanoma	RAP1GAP SETDB1 FASN BRCA2 PTPRO	1.59e-03	248	100	5	C0025202
Disease	response to ketamine	ARHGAP26 NR3C1 KIAA1671	1.68e-03	69	100	3	EFO_0009748
Disease	breast cancer (is_implicated_in)	PPM1D RB1CC1 BRCA2 UBR5	1.72e-03	150	100	4	DOID:1612 (is_implicated_in)
Disease	Malignant Glioma	PPM1D DMXL1 BRCA2	1.75e-03	70	100	3	C0555198
Disease	mixed gliomas	PPM1D DMXL1 BRCA2	1.75e-03	70	100	3	C0259783
Disease	gamma-aminoisobutyric acid measurement	AOC1 TACC2	1.87e-03	19	100	2	EFO_0010482
Disease	chronic kidney disease (is_marker_for)	SALL1 SIX2	2.08e-03	20	100	2	DOID:784 (is_marker_for)
Disease	Mammary Carcinoma, Human	PPM1D RB1CC1 ZNF365 SLC2A10 FASN BRCA2 FGD5	2.09e-03	525	100	7	C4704874
Disease	Mammary Neoplasms, Human	PPM1D RB1CC1 ZNF365 SLC2A10 FASN BRCA2 FGD5	2.09e-03	525	100	7	C1257931
Disease	Mammary Neoplasms	PPM1D RB1CC1 ZNF365 SLC2A10 FASN BRCA2 FGD5	2.14e-03	527	100	7	C1458155
Disease	cystatin C measurement	PPM1D NSD1 ADGRV1 USP37 SALL1 KIAA2012	2.50e-03	402	100	6	EFO_0004617
Disease	lymphocyte count, response to vaccine	ARHGAP26 HECW2	2.51e-03	22	100	2	EFO_0004587, EFO_0004645
Disease	Renal glomerular disease	NPHS1 SALL1	2.75e-03	23	100	2	C0268731
Disease	Glomerulopathy Assessment	NPHS1 SALL1	2.75e-03	23	100	2	C4521256
Disease	Anhedonia	ANK3 SETDB1	2.99e-03	24	100	2	C0178417
Disease	Glioma	PPM1D DMXL1 BRCA2	3.26e-03	87	100	3	C0017638

Protein segments in the cluster

Peptide	Gene	Start	Entry
TLAPDSPFDHKTVSG	CDY1	141	Q9Y6F8
EKPESLHSFSVEAPV	ANAPC4	96	Q9UJX5
HTEPVSLFPEESSGE	VCAN	1536	P13611
SVREDSEHGEKPVPS	ALS2	356	Q96Q42
SEEVTGQFSVHPETP	CEACAM8	131	P31997
FHVELTSPPTTEGFK	GYS2	621	P54840
HGTPAVSEKPDVATV	ADGRV1	5196	Q8WXG9
HSKFFEEPEDPSSRS	PPP2R2D	271	Q66LE6
VHDPFSDVSDSSFPK	ARID1B	1306	Q8NFD5
KGHDSTEEPPLFSSH	AOC1	271	P19801
TDGPLVTDPETHKST	FXYD5	81	Q96DB9
PETHIFTAPEEGSSQ	DMRTC1;	31	Q5HYR2
SHDSPVKAVAVDPTE	DMXL1	2926	Q9Y485
DESFKSEHTVFVTPP	DENND4A	666	Q7Z401
QDSTPESRHGAVKSP	NSD1	211	Q96L73
HSLPEASVSSKPDEG	OTUD4	921	Q01804
HPSKQGSPTEHEDVT	ITPR2	951	Q14571
KGIPVDDTDRHSPSS	PLA2G2C	51	Q5R387
YKHEGLAETPETSPE	ANK2	2231	Q01484
EGVTVKSSSHFNPDP	ANXA8	11	P13928
PVSEDSAADGTPKHS	HECW2	371	Q9P2P5
TSFPKSVEHVSPDTA	RB1CC1	256	Q8TDY2
ESSTGSPEEPNKFHS	FHDC1	556	Q9C0D6
EPDSAGHTKISTSIP	MUC16	711	Q8WXI7
PDTEVTTISHFPEKT	MUC16	2256	Q8WXI7
PDHDKSTVPPDTFTG	MUC16	5236	Q8WXI7
EHPTPLTKVAAAGDS	NPHS1	841	O60500
ADSAGPKTVPSHVFS	ELOA2	446	Q8IYF1
SPDEHILTPDSSFSK	MAP1A	1311	P78559
TSQVTPAEEKDGHSP	MAP1A	2651	P78559
PTEPKDTDTLVHEAG	KIAA1671	1521	Q9BY89
VDTHVDPPFHKSSDG	MDP1	21	Q86V88
GVEDIKSHPFFTPVD	RPS6KC1	1046	Q96S38
PAGTDETATHKDLIP	SLC2A10	186	O95528
VDGSLSDSHVSPPAK	ATAD2B	76	Q9ULI0
IEESTPVHDSPGKDD	KMT5B	626	Q4FZB7
AKDSHPSEEPVKSFS	DDX59	81	Q5T1V6
VDSAAETPPREGKSH	HSPB3	56	Q12988
VSTKFADEHVPGSPF	FLNB	2071	O75369
ADEHVPGSPFTVKIS	FLNB	2076	O75369
TTSKHIPQTDTEGDP	NAV3	2331	Q8IVL0
KPHLSEVTTEGYPSE	FAM234B	71	A2RU67
PEKEEGSSEVGPIFH	FGD5	1416	Q6ZNL6
SHPDSPENEKTETTF	PHF21A	451	Q96BD5
EDAGPESTKPVGVFH	NFX1	201	Q12986
ESTKPVGVFHPDSSE	NFX1	206	Q12986
PESQKGVDSPRTSDH	KIAA2012	551	Q0VF49
PTEKEFPKTHSDVSS	NR3C1	151	P04150
GEFVVSPEPDTSVHT	PPM1D	286	O15297
KTSPHTPNEKFEGAT	P3H2	496	Q8IVL5
VKHEAVSDQTSGEPP	PITPNM2	271	Q9BZ72
GPSTHPKEKAFSSEI	MSL1	406	Q68DK7
HFTEETPEIPSGNIS	PTPRO	266	Q16827
SPDHPVVKSEFESSP	BTBD18	436	B2RXH4
SAEKSPEASHTGPAF	ICE1	1466	Q9Y2F5
EGVTVKSSSHFNPDP	ANXA8L1	11	Q5VT79
TPKHISESLGAEVDP	BRCA2	176	P51587
TVSVSAVHDEGESPP	COL12A1	1631	Q99715
PHGVPDKSSVQSDEV	GBA2	806	Q9HCG7
PEDRKSSTPGSLHEE	CACNA1S	1751	Q13698
VAENSPPGTSVHKFS	CDHR3	31	Q6ZTQ4
PKEPTIEHGDSSFSL	FRMPD1	1001	Q5SYB0
PGKESPSSDVFDHSP	ANK3	3056	Q12955
EVVTGSTHPAEAAPE	MDFI	36	Q99750
GEKAPEPISTQSHSV	MASP1	261	P48740
QHPKPDTTVSGDTET	EMILIN2	231	Q9BXX0
EDKPEEPTAHAFVST	FASN	1521	P49327
GPETHPKSIDIFDFT	BMP2KL	171	Q5H9B9
IPTTATPTHDEKGEE	PRDM13	121	Q9H4Q3
PETVDDVEKLGSPHS	SLC22A3	526	O75751
GFVHVSPQDSKDTPT	SALL1	1091	Q9NSC2
EPHSDENGSTTPKVK	CEBPZ	146	Q03701
SHPREKGQTTPDTEA	DRP2	901	Q13474
HKPTVSAFFTGPEEL	KBTBD6	26	Q86V97
AAEPKEVPAHSTEVG	LRRFIP1	481	Q32MZ4
PSVSHKPFESIDEGQ	HGD	66	Q93099
YKPGSESVHTVDKPT	PNPLA8	256	Q9NP80
RPFTATTKPEHEDQG	RXFP3	416	Q9NSD7
VPEHFTLPDSTKSGV	SZT2	516	Q5T011
PTGESSEPEAKVLHT	SMG5	6	Q9UPR3
SKPDDSTEAHEGDPT	SAMSN1	36	Q9NSI8
PTEGPRKSVSSASEH	PRR36	201	Q9H6K5
PEEAVHEDSSTPFRK	ARHGAP26	746	Q9UNA1
KTPDSGHVSQEPKSE	RAP1GAP	521	P47736
IKREGESPTASPHSS	RNF220	276	Q5VTB9
DVHTKEPPSAETGST	METTL22	71	Q9BUU2
IKSTVCGPESFTPDH	SARDH	376	Q9UL12
ENGLSETTSKDSHPP	SETDB1	936	Q15047
HADDKETSFSPDTPL	C10orf90	226	Q96M02
PGLPTSDTKASFEAH	ZNF365	146	Q70YC5
AEVAPGKTHTDPTST	RP1L1	1706	Q8IWN7
TVLFFSGKVEPPHSS	TMEM94	431	Q12767
DTEEPTKDPDVAFHG	PSD2	56	Q9BQI7
AVEKTDSETMHGPPF	ZNF587	191	Q96SQ5
PFHSELTEKSSPEET	ZBTB41	181	Q5SVQ8
GHKTTGSPSDEEPEV	TTBK2	571	Q6IQ55
AVEKTDSETMHGPPF	ZNF417	191	Q8TAU3
PSHSFSAVFDEDKPI	TACC2	2016	O95359
SSEDEKTPSGTPDHS	SIX2	211	Q9NPC8
HEDDDKPTSSPDTGF	USP37	726	Q86T82
TLPDFSDPETGSVHA	TTC7B	646	Q86TV6
GEHLPFLTSVSDKPT	ZGRF1	586	Q86YA3
KGTTEEAPAKESPHT	TPTE2	11	Q6XPS3
EAPAKESPHTSEFKG	TPTE2	16	Q6XPS3
DHITFVAETGPKPSE	TGM7	56	Q96PF1
DSSEHGAPDSKEKTP	WBP1L	226	Q9NX94
PAPSEKSHEETDSTK	SCG3	356	Q8WXD2
TFHTPSLGDEEFEIP	TOX4	26	O94842
QSHEPVPDTSVEKGF	YEATS2	371	Q9ULM3
ETESSKPGPSAHDLA	UBR5	2131	O95071